Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025.
Zambrano LD, Simeone RM, Newhams MM, Payne AB, Halasa NB, Orzel-Lockwood AO, Calixte JM, Kamidani S, Crandall H, Cameron MA, Schuster JE, Maddux AB, Chiotos K, Irby K, Shein SL, Staat MA, Martin LM, Bhumbra SS, Nofziger RA, Chauhan JC, Zerr DM, Gertz SJ, Guzman-Cottrill JA, Kong M, Hume JR, Coates BM, Michelson KN, Levy ER, Bradford TT, Schwartz SP, Walker TC, Stockwell MS, Biggs A, Hogan AH, Lindsey K, Campbell AP, Randolph AG; Overcoming RSV Investigators.
Zambrano LD, et al.
MMWR Morb Mortal Wkly Rep. 2025 Nov 20;74(37):580-588. doi: 10.15585/mmwr.mm7437a1.
MMWR Morb Mortal Wkly Rep. 2025.
PMID: 41348586
Free article.